top of page
43169222_s.jpg
Mercati

Chiusura borse

Logotipo_Sfondo_Cultured_White  .png

2022

VALORIZZAZIONE E PROTEZIONE
DEL PATRIMONIO:

DALLA FINANZA
ALLE ATTIVITÀ REALI

Calendario economico
Indici
Tassi di cambio Forex
Mercato criptovalute
Il titolo di mio interesse
Market advisor
How Instacart's CEO Fidji Simo Brought French Style to Silicon Valley | The Circuit with Emily Chang
24:02

How Instacart's CEO Fidji Simo Brought French Style to Silicon Valley | The Circuit with Emily Chang

Emily Chang meets Instacart CEO Fidji Simo in her hometown in the South of France, and learns about her journey from a small fishing village to the C-Suite in Silicon Valley. Simo and Chang catch up again in San Francisco to discuss how she’s leading grocery delivery giant Instacart, navigating challenges of the gig economy and grocery prices, and Simo’s role as an OpenAI board member. Hosted by high-profile journalist Emily Chang, The Circuit is a fast-paced, dynamic series that lives at the intersection of culture, tech, entertainment, and business. Every week, Chang will go on location to meet the world’s most fascinating founders, influencers, and innovators, conducting intimate interviews and bringing audiences behind the scenes of the most impactful stories, launches, and trends. Watch more of The Circuit with Emily Chang: https://www.youtube.com/playlist?list=PLqq4LnWs3olV2nw7GgFjXHvxVc3T5hXXT #Business #France #Instacart -------- Like this video? Subscribe: http://www.youtube.com/Bloomberg?sub_confirmation=1 Get unlimited access to Bloomberg.com for $1.99/month for the first 3 months: https://www.bloomberg.com/subscriptions?in_source=YoutubeOriginals Bloomberg Originals offers bold takes for curious minds on today’s biggest topics. Hosted by experts covering stories you haven’t seen and viewpoints you haven’t heard, you’ll discover cinematic, data-led shows that investigate the intersection of business and culture. Exploring every angle of climate change, technology, finance, sports and beyond, Bloomberg Originals is business as you’ve never seen it. Subscribe for business news, but not as you've known it: exclusive interviews, fascinating profiles, data-driven analysis, and the latest in tech innovation from around the world. Visit our partner channel Bloomberg Quicktake for global news and insight in an instant.
The Weight-Loss Drug Market Is Hot. Which Medical Stock Will Win The Battle For Supremacy?
07:56

The Weight-Loss Drug Market Is Hot. Which Medical Stock Will Win The Battle For Supremacy?

The market for weight-loss drugs is expanding in a big way. Industry experts now say annual sales could hit $150 billion in just a few years, making losing weight one of the world's largest pharmaceutical markets. This is mostly due to big players like Novo Nordisk and Eli Lilly, makers of drugs such as Ozempic and Mounjaro. Lately, however, new competition has come to the table, and they're working on therapies to improve weight loss and mitigate gastrointestinal side effects. So, which weight-loss drug will come out as the ultimate heavyweight champion? New to trading? Check out our daily newsletter! https://get.investors.com/marketdiem/ Get more IBD by subscribing to our channel: https://www.youtube.com/@investorsbusinessdaily Visit our website: https://www.investors.com Like us on Facebook: https://www.facebook.com/investorsbusinessdaily Follow us on Twitter: https://twitter.com/IBDinvestors Follow us on Instagram: https://www.instagram.com/investorsbusinessdaily/ Follow us on StockTwits: https://stocktwits.com/InvestorsBusinessdaily Follow us on LinkedIn: https://www.linkedin.com/company/investors-business-daily Follow us on TikTok: https://www.tiktok.com/@ibdinvestors Investor’s Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market. #InvestorsBusinessDaily #IBD
Focus sugli ETF 20 novembre 2024
02:13

Focus sugli ETF 20 novembre 2024

Salgono sul podio della settimana l'ETF gestito da Amundi, che investe sulle principali società che operano nelle energie rinnovabili e nell'efficienza energetica, e l'ETF controllato da Ishares, che investe sui principali titoli azionari del mercato australiano. Hanno registrato la peggiore performance nella settimana l'ETF gestito da Ishares, composto da società che operano nella tecnologia e trattamenti medici, e l'ETF di Amundi, che rappresenta le società più capitalizzate quotate in Grecia. Hanno mosso i maggiori volumi di scambi l'ETF gestito da Amundi, che punta sulle società farmaceutiche più capitalizzate, e l'ETF di Deutsche Bank, esposto sui principali titoli azionari americani, con reinvestimento dei dividendi. Ecco gli ETF nel mirino degli analisti. Possibile rialzo per l'ETF emesso da Amundi, composto dalle azioni più capitalizzate dei mercati sviluppati. Forte interesse per l'ETF gestito da Deutsche Bank, costituito dalle azioni di 23 Paesi sviluppati. Invito all'acquisto per l'ETF di Ishares, che investe sui principali titoli azionari mondiali a più bassa volatilità. Riflettori puntati sull'ETF gestito da Lyxor, rappresentativo delle principali società americane, fatta eccezione per i settori dei trasporti e dei servizi di pubblica utilità. Visita il nostro sito: https://www.teleborsa.it/ ------------------------------------------------ Sui social Facebook: https://www.facebook.com/Teleborsa/ Twitter: https://twitter.com/teleborsa Linkedin: https://www.linkedin.com/company/teleborsa-s-p-a-/
bottom of page